Mildly Elevated Thyroid Antibodies with Normal Thyroid Function: Impact on Fertility
Women with mildly elevated thyroid antibodies (anti-TPO or anti-TG) but normal thyroid function tests are at increased risk for difficulty conceiving and should have their TSH monitored and optimized to below 2.5 mIU/L when attempting pregnancy.
Key Evidence and Recommendations
The 2012 Endocrine Society guidelines explicitly identify women with thyroid antibodies as a high-risk group for infertility 1. While universal screening for thyroid antibodies is not recommended, once antibodies are identified, specific management is warranted.
Impact on Fertility and Conception
The presence of thyroid antibodies does affect fertility outcomes, even when thyroid function appears normal:
Increased miscarriage risk: Women with positive thyroid antibodies have a 2- to 5-fold increased risk of miscarriage in unselected populations, even when euthyroid 1. This association has been demonstrated in both natural conception and assisted reproductive technology (ART) settings 2.
Embryo quality concerns: Recent evidence shows that positive anti-TPO antibodies are associated with decreased ovarian reserve (lower AMH levels), reduced high-quality embryo rates (40% vs 45%), and lower live birth rates (23% vs 36%) 3. Higher antibody titers correlate with worse outcomes, with live birth rates of only 14% in high-titer groups versus 33% in low-titer groups 3.
Subtle thyroid dysfunction: Women with thyroid antibodies often have TSH levels in the higher-normal range, which may still impair fertility. The guidelines note that TSH levels are "slightly but significantly higher (within the normal range)" in antibody-positive women 1.
Clinical Management Algorithm
For women with known thyroid antibodies attempting pregnancy:
Check TSH level - Even if previously "normal," verify current value 1
If TSH > 2.5 mIU/L: Start levothyroxine to bring TSH below 2.5 mIU/L before conception 1. This is a specific recommendation for women planning pregnancy, distinct from general population management.
If TSH ≤ 2.5 mIU/L: Monitor TSH during first and second trimesters, as antibody-positive women are at risk for progression to hypothyroidism during pregnancy 1
Counsel about increased risks: Inform patients about elevated risks of miscarriage, preterm delivery, and postpartum thyroiditis 1
Important Nuances
The evidence shows mixed results on whether antibodies alone (with truly normal TSH) impair conception rates:
- Some studies found no impact on pregnancy rates when TSH was controlled 4, 5
- However, other studies demonstrate impaired embryo quality and live birth rates even in euthyroid antibody-positive women 3, 6
- The most recent high-quality evidence (2023-2025) consistently shows adverse outcomes including lower birth weight, higher NICU admission rates, and increased pregnancy complications 7, 8
Critical distinction: The issue is not just about getting pregnant initially, but about maintaining pregnancy and achieving live birth. The miscarriage risk is well-established 1, 2, 7.
Common Pitfalls to Avoid
Don't assume "normal" TSH is adequate: The pregnancy-specific TSH threshold of 2.5 mIU/L is lower than the general population upper limit. A TSH of 3.5 mIU/L may be "normal" for non-pregnant individuals but is too high for conception 1, 9.
Don't ignore antibodies once identified: While universal screening isn't recommended, once antibodies are known, they mandate closer monitoring 1.
Don't wait until pregnancy is confirmed: Optimize TSH before conception, as thyroid hormone requirements increase immediately upon conception 1.
Bottom Line for Clinical Practice
Yes, mildly elevated thyroid antibodies with normal thyroid function tests do affect pregnancy outcomes. The primary mechanism appears to be through increased miscarriage risk and potential subtle thyroid dysfunction that worsens during pregnancy. The practical approach is to ensure TSH is optimized to <2.5 mIU/L before conception attempts and to monitor closely during pregnancy 1.